Targeted Nutritional Intervention for Patients with Mild Cognitive Impairment: The Cognitive impAiRmEnt Study (CARES) Trial 1

被引:21
作者
Power, Rebecca [1 ]
Nolan, John M. [1 ]
Prado-Cabrero, Alfonso [1 ]
Coen, Robert [2 ]
Roche, Warren [1 ]
Power, Tommy [1 ]
Howard, Alan N. [3 ]
Mulcahy, Riona [4 ,5 ]
机构
[1] Waterford Inst Technol, Sch Hlth Sci, Nutr Res Ctr Ireland, Carriganore House,West Campus, Waterford X91 K0EK, Ireland
[2] St James Hosp, Mercers Inst Res Ageing, Dublin D08 NHY1, Ireland
[3] Howard Fdn, 7 Marfleet Close, Cambridge CB22 5LA, England
[4] Univ Hosp Waterford, Age Related Care Unit, Dunmore Rd, Waterford X91 ER8E, Ireland
[5] Royal Coll Surgeons Ireland, 123 Stephens Green, Dublin D02 YN77, Ireland
来源
JOURNAL OF PERSONALIZED MEDICINE | 2020年 / 10卷 / 02期
关键词
mild cognitive impairment; nutrition; omega-3 fatty acids; antioxidant; carotenoids; vitamin E; cognition; episodic memory; older adults; ageing; ALZHEIMERS-DISEASE; MEDITERRANEAN DIET; DOCOSAHEXAENOIC ACID; MACULAR PIGMENT; OMEGA-3-FATTY-ACID SUPPLEMENTATION; OLDER-ADULTS; DOUBLE-BLIND; DEMENTIA; CAROTENOIDS; MEMORY;
D O I
10.3390/jpm10020043
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Omega-3 fatty acids (omega-3FAs), carotenoids, and vitamin E are important constituents of a healthy diet. While they are present in brain tissue, studies have shown that these key nutrients are depleted in individuals with mild cognitive impairment (MCI) in comparison to cognitively healthy individuals. Therefore, it is likely that these individuals will benefit from targeted nutritional intervention, given that poor nutrition is one of the many modifiable risk factors for MCI. Evidence to date suggests that these nutritional compounds can work independently to optimize the neurocognitive environment, primarily due to their antioxidant and anti-inflammatory properties. To date, however, no interventional studies have examined the potential synergistic effects of a combination of omega-3FAs, carotenoids and vitamin E on the cognitive function of patients with MCI. Individuals with clinically confirmed MCI consumed an omega-3FA plus carotenoid plus vitamin E formulation or placebo for 12 months. Cognitive performance was determined from tasks that assessed global cognition and episodic memory. omega-3FAs, carotenoids, and vitamin E were measured in blood. Carotenoid concentrations were also measured in tissue (skin and retina). Individuals consuming the active intervention (n= 6; median [IQR] age 73.5 [69.5-80.5] years; 50% female) exhibited statistically significant improvements (p< 0.05, for all) in tissue carotenoid concentrations, and carotenoid and omega-3FA concentrations in blood. Trends in improvements in episodic memory and global cognition were also observed in this group. In contrast, the placebo group (n= 7; median [IQR] 72 (69.5-75.5) years; 89% female) remained unchanged or worsened for all measurements (p> 0.05). Despite a small sample size, this exploratory study is the first of its kind to identify trends in improved cognitive performance in individuals with MCI following supplementation with omega-3FAs, carotenoids, and vitamin E.
引用
收藏
页数:29
相关论文
共 93 条
  • [1] Quantifying memory deficits in amnestic mild cognitive impairment
    Andres, Pilar
    Vico, Helena
    Yanez, Aina
    Siquier, Antonia
    Ferrer, Guillermo Amer
    [J]. ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2019, 11 (01) : 108 - 114
  • [2] Does omega-3 fatty acid supplementation enhance neural efficiency? A review of the literature
    Bauer, Isabelle
    Crewther, Sheila
    Pipingas, Andrew
    Sellick, Laura
    Crewther, David
    [J]. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2014, 29 (01) : 8 - 18
  • [3] Standard Reference Material (SRM) 2378 fatty acids in frozen human serum. Certification of a clinical SRM based on endogenous supplementation of polyunsaturated fatty acids
    Benner, Bruce A., Jr.
    Schantz, Michele M.
    Powers, Carissa D.
    Schleicher, Rosemary L.
    Camara, Johanna E.
    Sharpless, Katherine E.
    Yen, James H.
    Sniegoski, Lorna T.
    [J]. ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2018, 410 (09) : 2321 - 2329
  • [4] Impact of Mild Cognitive Impairment on Mortality and Cause of Death in the Elderly
    Bin Bae, Jong
    Han, Ji Won
    Kwak, Kyung Phil
    Kim, Bong Jo
    Kim, Shin Gyeom
    Kim, Jeong Lan
    Kim, Tae Hui
    Ryu, Seung-Ho
    Moon, Seok Woo
    Park, Joon Hyuk
    Youn, Jong Chul
    Lee, Dong Young
    Lee, Dong Woo
    Lee, Seok Bum
    Lee, Jung Jae
    Jhoo, Jin Hyeong
    Kim, Ki Woong
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2018, 64 (02) : 607 - 616
  • [5] Topographical Short-Term Memory Differentiates Alzheimer's Disease From Frontotemporal Lobar Degeneration
    Bird, Chris M.
    Chan, Dennis
    Hartley, Tom
    Pijnenburg, Yolande A.
    Rossor, Martin N.
    Burgess, Neil
    [J]. HIPPOCAMPUS, 2010, 20 (10) : 1154 - 1169
  • [6] The n-3 Polyunsaturated Fatty Acids Supplementation Improved the Cognitive Function in the Chinese Elderly with Mild Cognitive Impairment: A Double-Blind Randomized Controlled Trial
    Bo, Yacong
    Zhang, Xueyuan
    Wang, Youli
    You, Jie
    Cui, Han
    Zhu, Yiwei
    Pang, Wei
    Liu, Wei
    Jiang, Yugang
    Lu, Quanjun
    [J]. NUTRIENTS, 2017, 9 (01)
  • [7] Bouayed J., DIETARY DERIVED ANTI
  • [8] A randomized placebo-controlled study on the effects of lutein and zeaxanthin on visual processing speed in young healthy subjects
    Bovier, Emily R.
    Hammond, Billy R.
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2015, 572 : 54 - 57
  • [9] Plasma omega-3 PUFA and white matter mediated executive decline in older adults
    Bowman, Gene L.
    Dodge, Hiroko H.
    Mattek, Nora
    Barbey, Aron K.
    Silbert, Lisa C.
    Shinto, Lynne
    Howieson, Diane B.
    Kaye, Jeffrey A.
    Quinn, Joseph F.
    [J]. FRONTIERS IN AGING NEUROSCIENCE, 2013, 5
  • [10] Britton G., 1995, Carotenoids, V1